Analysis of the survival curve revealed that the higher mevalonate pathway associated genes (HMGCR, HMGCS1 and INSIG2) levels were correlated with lower survival times for the breast cancer patients [26] (Supplementary Figure 1C). This evidence concerns the gene HMGCR and breast carcinoma.